Reaction Details |
| Report a problem with these data |
Target | Cannabinoid receptor 1 |
---|
Ligand | BDBM50267487 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_563052 (CHEMBL1011882) |
---|
IC50 | 1.2±n/a nM |
---|
Citation | Vachal, P; Fletcher, JM; Fong, TM; Huang, CC; Lao, J; Xiao, JC; Shen, CP; Strack, AM; Shearman, L; Stribling, S; Chen, RZ; Frassetto, A; Tong, X; Wang, J; Ball, RG; Tsou, NN; Hickey, GJ; Thompson, DF; Faidley, TD; Nicolich, S; Achanfuo-Yeboah, J; Hora, DF; Hale, JJ; Hagmann, WK 1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity. J Med Chem52:2550-8 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cannabinoid receptor 1 |
---|
Name: | Cannabinoid receptor 1 |
Synonyms: | CANN6 | CANNABINOID CB1 | CB-R | CB1 | CNR | CNR1 | CNR1_HUMAN | Cannabinoid CB1 receptor | Cannabinoid receptor | Cannabinoid receptor 1 (CB1) | Cannabinoid receptor 1 (brain) |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 52868.96 |
Organism: | Homo sapiens (Human) |
Description: | P21554 |
Residue: | 472 |
Sequence: | MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQE
KMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIA
VLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVF
HRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLM
WTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWK
AHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLL
AIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQ
PLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
|
|
|
BDBM50267487 |
---|
n/a |
---|
Name | BDBM50267487 |
Synonyms: | 1-(4-(3-cyclopropyl-5-(trifluoromethyl)phenylsulfonyl)piperazin-1-yl)-2-(4-(trifluoromethyl)phenyl)ethanone | CHEMBL516900 |
Type | Small organic molecule |
Emp. Form. | C23H22F6N2O3S |
Mol. Mass. | 520.488 |
SMILES | FC(F)(F)c1ccc(CC(=O)N2CCN(CC2)S(=O)(=O)c2cc(cc(c2)C(F)(F)F)C2CC2)cc1 |
Structure |
|